Safety Considerations and Monitoring in Patients Treated with Systemic Medications for Acne

被引：8
作者：
Park, Hyunhee [1 ]
Skopit, Stanley [2 ]
机构：
[1] Larkin Community Hosp NSU COM, Dept Dermatol, 4970 West Atlantic Blvd, Margate, FL 33063 USA
[2] Larkin Community Hosp NSU COM, Dermatol Residency Program, 4970 West Atlantic Blvd, Margate, FL 33063 USA
来源：
DERMATOLOGIC CLINICS | 2016年 / 34卷 / 02期
关键词：
Acne; Systemic treatments; Safety; Monitoring; Oral antibiotics; Spironolactone; Isotretinoin; PATIENTS RECEIVING ISOTRETINOIN; LOW-DOSE ISOTRETINOIN; SPIRONOLACTONE THERAPY; ORAL SPIRONOLACTONE; DRUG REACTION; DOUBLE-BLIND; MINOCYCLINE; DOXYCYCLINE; VULGARIS; WOMEN;
D O I：
10.1016/j.det.2015.11.004
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
Acne vulgaris, a disorder of the pilosebaceous unit, is one of the most commonly encountered conditions in dermatology practice. Effective treatment of acne vulgaris is important in that it can prevent psychosocial distress and physical scarring. Systemic therapeutic options are available for moderate to severe acne. It is imperative that the safe and effective treatment revolves around the health care provider's familiarity of side effects of various treatments. In this article, the side effects and monitoring guide for the most commonly prescribed systemic agents for acne vulgaris are reviewed.
引用
收藏
页码：185 / +
页数：10
相关论文
共 100 条
12345678910